Simon Says Stop: What a Children’s Game Can Teach Us About Early Huntington’s Disease
Do you remember playing “Simon Says” as a child? It was fun, silly, and surprisingly tricky. You had to listen carefully and only act when you heard “Simon says”. If you moved at the wrong time, you were out. It turns out that Simon Says isn’t just a playground game. It’s also a helpful way […]
Energy off balance: How Huntington’s disease influences the cell’s powerhouse
A recent study used miniature 3D brain models grown from stem cells to explore how the genetic change that causes Huntington’s disease (HD) might impact early brain development, before neurons even become neurons. What they found suggests that the tipping point that balances how cells mature may be off, and it could be because of […]
Peeking at huntingtin and learning from a PET study
A recent publication discusses a non-invasive way of measuring levels of expanded HTT protein in the brain, using an imaging tool called a PET tracer. The results were variable, but there’s still a lot to learn from the study as development of HTT tracers continues! Measuring Levels Of Huntingtin In The Brain One of the […]
June 2025: This Month in Huntington’s Disease Research
Welcome to your June roundup of the latest and greatest Huntington’s disease (HD) research, served up fresh and easy to digest! This month, we’ve got gene therapies revving up, brain wiring revealing surprising detours, and molecular firefighters missing in action. From emotional rollercoasters inside the brain to decoding irritability storms, June’s science brings us closer […]
Trouble on the Block: When the Neighborhood Loses Its Best Firefighter
Picture a quiet neighborhood. Things used to run smoothly here. Kids played outside, front yards were mowed, and the neurons — the longtime residents — looked out for one another. But lately, fires are breaking out. And worst of all? The neighborhood’s most important firefighter, PKD1, has stopped showing up. That metaphor details findings from […]
Spark ignited: first HD patient dosed in new Roche gene therapy trial
Spark Therapeutics, recently integrated into Roche Pharmaceuticals, has been working on an HD gene therapy. It’s delivered via a one-time brain surgery and is designed to lower levels of the huntingtin protein. A (very) small safety study has recently begun, and so far, one brave individual has received this experimental therapy, known as RG6662 (or […]
EN 
ES 
IT 
DE 
FR